查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1650894

全球癌症诊断药物市场

Cancer Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球癌症诊断市场规模将达到 3,361 亿美元

2024 年全球癌症诊断市场规模估计为 2,398 亿美元，预计 2030 年将达到 3,361 亿美元，2024 年至 2030 年的复合年增长率为 5.8%。诊断影像是报告中分析的细分市场之一，预计到分析期结束时复合年增长率为 6.8%，达到 953 亿美元。在分析期内，临床测试部分预计将以 4.1% 的复合年增长率成长。

美国市场规模估计为 625 亿美元，中国市场预计年均成长率为 8.8%

预计2024年美国癌症诊断市场规模将达625亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 779 亿美元，2024-2030 年分析期间的复合年增长率为 8.8%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 2.9% 和 5.3%。在欧洲，德国的复合年增长率预计为 3.4%。

全球癌症诊断市场 - 主要趋势和驱动因素摘要

为什么癌症诊断处于医学创新的前沿？

癌症诊断是医疗保健的关键领域，为癌症的早期发现、诊断和监测提供必不可少的工具，显着改善患者的治疗效果。准确、早期诊断癌症的能力对于成功治疗和存活率有着巨大的影响。多年来，癌症诊断已从基本的影像技术发展到高度复杂的分子和基因测试，能够识别特定的癌症类型、其进展以及可能影响治疗决策的基因突变。各种诊断技术（包括切片检查、血液检查、成像（例如 MRI 和电脑断层扫描）和基因组分析）的整合为临床医生提供了患者癌症的全面视图。此外，液态切片和次世代定序（NGS）的进步彻底改变了早期癌症的检测和监测方式。随着该领域的进步，癌症诊断变得更加准确和个人化，在製定治疗策略和提高患者存活率方面发挥关键作用。

科技创新如何推动癌症诊断？

科技创新的快速发展正在彻底改变癌症诊断领域，带来能够更准确、更早检测的新工具和技术。最重要的发展之一是基因组和分子诊断的兴起，它为了解驱动癌症生长的基因突变提供了基础。次世代定序(NGS) 可以全面分析患者的基因特征，帮助临床医生根据每个患者癌症的独特特征制定治疗方案，使个人化医疗成为现实。液态切片是另一个尖端进步，可以透过简单的血液检查检测出癌症。该技术不仅有助于早期发现，还能监测癌症的进展和治疗的效果。人工智慧（AI）和机器学习也透过增强诊断成像、提高癌症筛检的准确性以及比以往更快地解释复杂资料集证明了其价值。这些创新简化了诊断过程，实现了更早的检测，并透过更精确和个人化的治疗方法改善了患者的治疗效果。

癌症诊断药物面临哪些新趋势与挑战？

目前，有几个关键趋势正在影响癌症诊断市场，每种趋势都会影响癌症的检测和管理方式。一个主要趋势是对非侵入性诊断的需求不断增长，例如液态切片和先进的成像技术，可以最大限度地减少患者的不适并减少获得结果所需的时间。这种向微创方法的转变正获得患者和医疗保健提供者的支持，因为他们寻求更安全、更方便的选择。另一个趋势是人们越来越意识到癌症筛检可以挽救生命，从而更加重视早期发现。乳癌、结肠癌、肺癌和其他癌症筛检计画的扩大，推动了对早期可发现癌症的诊断工具的需求。然而，该行业也面临一些挑战。先进诊断技术的复杂性和成本可能成为广泛采用的障碍，尤其是在中低收入地区。此外，基因组检测和影像诊断产生的大量资料需要复杂的资料管理和分析系统，这对医疗保健提供者在整合和解释方面提出了挑战。儘管存在这些挑战，个人化医疗和早期检测的趋势继续推动癌症诊断的创新。

癌症诊断药物市场规模扩大的原因是什么？

癌症诊断市场的成长受到多种因素的推动，包括技术进步、癌症发病率的上升以及对早期发现和个人化治疗的日益重视。其中一个主要成长要素是分子诊断需求的激增，尤其是次世代定序（NGS）和液态切片技术，它们为检测癌症提供了更准确、更少侵入性的选择。此外，个人化医疗的兴起，即根据个人基因特征制定治疗方案，刺激了对能够识别特定生物标记和突变的诊断工具的需求。此外，由于人口老化和生活方式相关的风险因素等因素导致全球癌症发病率上升，也推动了对能够更早发现癌症并改善患者预后的诊断解决方案的需求。此外，提倡定期癌症筛检的政府措施和医疗政策也推动了对诊断测试的需求，尤其是在新兴市场。此外，人工智慧和机器学习与诊断影像和资料分析的结合正在提高癌症检测的准确性和速度，这也是推动市场成长的主要因素。这些因素，加上诊断能力向新兴市场的持续扩张，预计未来几年癌症诊断产业将保持快速成长。

部分

类型（影像、实验室测试、基因测试、内视镜检查、切片检查、其他类型）；应用（乳房、肺癌、血液、大肠直肠癌、皮肤、前列腺、卵巢、其他应用）

受访公司范例（47家值得关注的公司）

  • Abbott Diagnostics
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambry Genetics Corporation
  • Applied Imaging
  • AstraZeneca PLC
  • AutoGenomics, Inc.
  • BARD, A Becton, Dickinson Company
  • Bayer AG
  • Becton, Dickinson and Company
  • BioCurex, Inc.
  • bioMeriux SA
  • Celara Diagnostics
  • Diagnostic Products Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Genoptix, Inc.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Illumina, Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • QIAGEN GmbH
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP10863

Global Cancer Diagnostics Market to Reach US$336.1 Billion by 2030

The global market for Cancer Diagnostics estimated at US$239.8 Billion in the year 2024, is expected to reach US$336.1 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. Growth in the Laboratory Tests segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$62.5 Billion While China is Forecast to Grow at 8.8% CAGR

The Cancer Diagnostics market in the U.S. is estimated at US$62.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$77.9 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Cancer Diagnostics Market - Key Trends and Drivers Summarized

Why Is Cancer Diagnostics at the Forefront of Medical Innovation?

Cancer diagnostics is a critical field within healthcare, providing essential tools for the early detection, diagnosis, and monitoring of cancer, significantly improving patient outcomes. The ability to diagnose cancer accurately and at an early stage can make a tremendous difference in treatment success rates and survival. Over the years, cancer diagnostics has evolved from basic imaging techniques to highly sophisticated molecular and genetic testing, enabling the identification of specific cancer types, their progression, and genetic mutations that may influence treatment decisions. The integration of various diagnostic technologies, such as biopsy, blood tests, imaging modalities (like MRI and CT scans), and genomic profiling, provides clinicians with a comprehensive view of a patient’s cancer. Moreover, advancements in liquid biopsy and next-generation sequencing (NGS) have transformed how early-stage cancer is detected and monitored. As the field advances, cancer diagnostics is becoming more precise and personalized, playing a crucial role in shaping treatment strategies and improving patient survival rates.

How Are Technological Innovations Driving Cancer Diagnostics?

The rapid pace of technological innovation is profoundly reshaping the cancer diagnostics landscape, bringing forth new tools and methodologies that allow for more accurate and earlier detection. One of the most significant developments has been the rise of genomic and molecular diagnostics, which provide insights into the genetic mutations driving cancer growth. Next-generation sequencing (NGS) enables the comprehensive analysis of a patient’s genetic profile, helping clinicians tailor treatments to the individual’s unique cancer characteristics, making personalized medicine a reality. Liquid biopsy, another cutting-edge advancement, allows for the detection of cancer through a simple blood test, offering a less invasive and faster alternative to traditional tissue biopsies. This technology is not only useful for early detection but also for monitoring cancer progression and treatment efficacy. Artificial intelligence (AI) and machine learning are also making their mark by enhancing imaging technologies, improving the accuracy of cancer screening, and allowing for the interpretation of complex datasets at an unprecedented speed. These innovations are streamlining diagnostic processes, enabling earlier detection, and facilitating better patient outcomes through more precise, individualized treatment approaches.

What Are the Emerging Trends and Challenges in Cancer Diagnostics?

Several key trends are currently shaping the cancer diagnostics market, each influencing how cancer is detected and managed. A major trend is the increasing demand for non-invasive diagnostics, such as liquid biopsy and advanced imaging techniques, which minimize patient discomfort and reduce the time needed to obtain results. This shift towards minimally invasive methods is gaining traction as patients and healthcare providers alike look for safer and more convenient options. Another trend is the growing emphasis on early detection, driven by rising awareness of cancer screening's life-saving potential. Screening programs for cancers such as breast, colorectal, and lung have expanded, leading to increased demand for diagnostic tools that can catch cancer at its earliest stages. However, the field faces several challenges as well. The complexity and cost of advanced diagnostic technologies can pose barriers to widespread adoption, particularly in low- and middle-income regions. Moreover, the sheer volume of data generated by genomic testing and imaging requires sophisticated data management and analysis systems, posing a challenge for healthcare providers in terms of integration and interpretation. Despite these challenges, the trend towards personalized medicine and early detection continues to propel innovation in cancer diagnostics.

What Factors Are Fueling the Expansion of the Cancer Diagnostics Market?

The growth in the cancer diagnostics market is driven by several factors, primarily advances in technology, rising cancer prevalence, and the increasing emphasis on early detection and personalized treatment. One of the key growth drivers is the surge in demand for molecular diagnostics, particularly next-generation sequencing (NGS) and liquid biopsy technologies, which provide more accurate and less invasive options for detecting cancer. The growing adoption of personalized medicine, where treatment plans are tailored to the individual’s genetic profile, has also spurred demand for diagnostic tools that can identify specific biomarkers and mutations. Additionally, the rising global incidence of cancer, driven by factors such as aging populations and lifestyle-related risk factors, is increasing the need for diagnostic solutions that can detect cancer early and improve patient outcomes. Government initiatives and healthcare policies promoting regular cancer screenings have also fueled the demand for diagnostic tests, particularly in developed markets. Another significant factor driving market growth is the integration of artificial intelligence and machine learning into diagnostic imaging and data analysis, which enhances the accuracy and speed of cancer detection. These factors, combined with the continued expansion of diagnostic capabilities into emerging markets, are expected to sustain the rapid growth of the cancer diagnostics industry in the years to come.

SCOPE OF STUDY:

The report analyzes the Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy, Other Types); Application (Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Diagnostics
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambry Genetics Corporation
  • Applied Imaging
  • AstraZeneca PLC
  • AutoGenomics, Inc.
  • BARD, A Becton, Dickinson Company
  • Bayer AG
  • Becton, Dickinson and Company
  • BioCurex, Inc.
  • bioMeriux SA
  • Celara Diagnostics
  • Diagnostic Products Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Genoptix, Inc.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Illumina, Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • QIAGEN GmbH
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Globally Spurs Growth in Demand for Cancer Diagnostics
    • Technological Advancements in Genomics Throw the Spotlight on Precision Cancer Diagnostics
    • Growth in Personalized Medicine Expands Addressable Market Opportunity for Advanced Diagnostic Tools
    • Increasing Focus on Early Detection Propels Adoption of Non-Invasive Cancer Diagnostic Techniques
    • Growing Use of Liquid Biopsy Accelerates Demand for Minimal Invasive Cancer Diagnostic Methods
    • Expanding Applications of Biomarker Testing Sustain Growth in Cancer Diagnostics
    • Innovations in Imaging and Screening Generate New Opportunities for Early Cancer Detection
    • Shift toward Point-of-Care Diagnostics Strengthens Demand for Portable Cancer Diagnostic Tools
    • Growth in Molecular Diagnostics Expands Market Potential for Targeted Cancer Screening
    • Growing Use of Next-Generation Sequencing Accelerates Precision Cancer Diagnostics Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Colorectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Skin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Skin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Skin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Prostate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Ovarian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Genetic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 43: World Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 104: Spain Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Spain Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Spain 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Spain 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 110: Russia Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Russia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Russia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 113: Russia Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Russia Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Russia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 131: Australia Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Australia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Australia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Australia Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Australia Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Australia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • INDIA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 137: India Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: India Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: India 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: India Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: India Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: India 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 143: South Korea Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: South Korea Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: South Korea 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 146: South Korea Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: South Korea Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: South Korea 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Asia-Pacific Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Asia-Pacific Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Latin America Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Latin America 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 161: Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Latin America Historic Review for Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Latin America 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 164: Argentina Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Argentina Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Argentina 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 167: Argentina Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Argentina Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Argentina 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 170: Brazil Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Brazil Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Brazil 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 173: Brazil Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Brazil Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Brazil 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 176: Mexico Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Mexico Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Mexico 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 179: Mexico Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Mexico Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Mexico 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Latin America Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Latin America 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Latin America Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Latin America 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Middle East Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Middle East 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 194: Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Middle East Historic Review for Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Middle East 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 197: Iran Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Iran Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Iran 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: Iran Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Iran Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Iran 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 203: Israel Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Israel Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Israel 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Israel Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Israel Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Israel 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Saudi Arabia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Saudi Arabia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Saudi Arabia Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Saudi Arabia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 215: UAE Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: UAE Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: UAE 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 218: UAE Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: UAE Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: UAE 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Middle East Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Middle East 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Middle East Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Middle East 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 227: Africa Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Africa Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Africa 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 230: Africa Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Africa Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Africa 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION